Westfield Capital Management CO LP Moon Lake Immunotherapeutics Transaction History
Westfield Capital Management CO LP
- $21.2 Billion
- Q3 2024
A detailed history of Westfield Capital Management CO LP transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Westfield Capital Management CO LP holds 1,167,358 shares of MLTX stock, worth $53.7 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
1,167,358
Previous 1,117,625
4.45%
Holding current value
$53.7 Million
Previous $49.1 Million
19.77%
% of portfolio
0.28%
Previous 0.25%
Shares
6 transactions
Others Institutions Holding MLTX
# of Institutions
125Shares Held
58.2MCall Options Held
52.2KPut Options Held
38K-
Bvf Inc San Francisco, CA21.8MShares$1 Billion34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$391 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$137 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$127 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$107 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.7B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...